These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2194155)
1. Cerebrospinal fluid B2-microglobulin levels in meningeal involvement by malignancy. Jeffery GM; Frampton CM; Legge HM; Hart DN Pathology; 1990 Jan; 22(1):20-3. PubMed ID: 2194155 [TBL] [Abstract][Full Text] [Related]
2. Beta 2-microglobulin levels in cerebrospinal fluid of children with leukemia and lymphoma. Pudek MR; Chan KW; Rogers PC; Teasdale JM Clin Biochem; 1985 Jun; 18(3):180-3. PubMed ID: 3888445 [TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNS-involvement. Hansen PB; Kjeldsen L; Dalhoff K; Olesen B Acta Neurol Scand; 1992 Mar; 85(3):224-7. PubMed ID: 1575009 [TBL] [Abstract][Full Text] [Related]
4. Beta 2-microglobulin, lysozyme and lactoferrin in cerebrospinal fluid in patients with lymphoma or leukaemia: relationship to CNS involvement and the effect of prophylactic intrathecal treatment with methotrexate. Oberg G; Hällgren R; Venge P Br J Haematol; 1987 Jul; 66(3):315-22. PubMed ID: 3304392 [TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of cerebrospinal fluid beta 2-microglobulin determination in central nervous system leukemia]. Zhang HZ; Ye X; Sun ZG Zhonghua Nei Ke Za Zhi; 1989 May; 28(5):262-4, 313. PubMed ID: 2680338 [TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid beta-2-microglobulin: a reliable index of leukaemic infiltration of central nervous system. Storti S; Pagano L; Marra R; Teofili L; Ricerca BM; Leone G; Bizzi B Scand J Haematol; 1986 Oct; 37(4):301-5. PubMed ID: 3538368 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determination. Mavlight GM; Stuckey SE; Cabanillas FF; Keating MJ; Tourtellotte WW; Schold SC; Freireich EJ N Engl J Med; 1980 Sep; 303(13):718-22. PubMed ID: 6157089 [TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid beta 2-microglobulin: a study in controls and patients with metastatic and non-metastatic neurological diseases. Twijnstra A; van Zanten AP; Nooyen WJ; Hart AA; Ongerboer de Visser BW Eur J Cancer Clin Oncol; 1986 Apr; 22(4):387-91. PubMed ID: 3525181 [TBL] [Abstract][Full Text] [Related]
9. Detection of central nervous system metastasis with cerebrospinal fluid beta-2-microglobulin. Koch TR; Lichtenfeld KM; Wiernik PH Cancer; 1983 Jul; 52(1):101-4. PubMed ID: 6189578 [TBL] [Abstract][Full Text] [Related]
10. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies. Kersten MJ; Evers LM; Dellemijn PL; van den Berg H; Portegies P; Hintzen RQ; van Lier RA; von dem Borne AE; van Oers RH Blood; 1996 Mar; 87(5):1985-9. PubMed ID: 8634448 [TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid beta-2-microglobulin level as marker of central nervous system involvement in lymphoma. Pagano L; Marra R; Storti S; De Stefano V; Bizzi B Haematologia (Budap); 1986; 19(2):121-5. PubMed ID: 3530906 [TBL] [Abstract][Full Text] [Related]
12. Elevation of cerebrospinal fluid sialic acid concentration in children with central nervous system leukemia. Asami T; Tanaka A; Gunji T; Sakai K; Asami K Acta Paediatr Scand; 1987 Mar; 76(2):260-5. PubMed ID: 3296627 [TBL] [Abstract][Full Text] [Related]
13. Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors. Twijnstra A; Ongerboer de Visser BW; van Zanten AP; Hart AA; Nooyen WJ J Neurooncol; 1989 May; 7(1):57-63. PubMed ID: 2666594 [TBL] [Abstract][Full Text] [Related]
14. Central nervous system relapse surveillance by serial beta 2-microglobulin measurements in childhood acute lymphoblastic leukemia. Clausen N; Ibsen KK Acta Paediatr Scand; 1984 Nov; 73(6):848-54. PubMed ID: 6395626 [TBL] [Abstract][Full Text] [Related]
15. Soluble L-selectin increases in the cerebrospinal fluid prior to meningeal involvement in children with acute lymphoblastic leukemia. Dagdemir A; Ertem U; Duru F; Kirazli S Leuk Lymphoma; 1998 Jan; 28(3-4):391-8. PubMed ID: 9517511 [TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy. van Zanten AP; Twijnstra A; Ongerboer de Visser BW; van Heerde P; Hart AA; Nooyen WJ J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):119-23. PubMed ID: 2019836 [TBL] [Abstract][Full Text] [Related]
17. Unreliability of beta-2-microglobulin in early detection of central nervous system relapse in acute lymphoblastic leukemia. Nagelkerke AF; van Kamp GJ; Veerman AJ; de Waal FC Eur J Cancer Clin Oncol; 1985 Jun; 21(6):659-63. PubMed ID: 3894031 [TBL] [Abstract][Full Text] [Related]
18. Significance and limits of cerebrospinal fluid beta-2-microglobulin measurement in course of acute lymphoblastic leukemia. Musto P; Tomasi P; Cascavilla N; Ladogana S; La Sala A; Melillo L; Nobile M; Castoldi G; Carotenuto M Am J Hematol; 1988 Aug; 28(4):213-8. PubMed ID: 3046340 [TBL] [Abstract][Full Text] [Related]
19. [CSF levels and diagnostic utility of cerebrospinal fluid beta2-microglobulin]. Caudie C; Bancel J; Dupont M; Matanza D; Poitevin F; Honnorat J Ann Biol Clin (Paris); 2005; 63(6):631-7. PubMed ID: 16330382 [TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid protein findings during prophylaxis and treatment of neuromeningosis in leukaemic patients. Marra R; Pagano L; Storti S; Massaro A; Teofili L; Carbone G; Leone G Scand J Clin Lab Invest; 1987 Dec; 47(8):765-9. PubMed ID: 3432998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]